Jun 4, 2026 04:48PM
Jun 2, 2026 08:01AM
Jun 2, 2026 08:00AM
May 26, 2026 06:59AM
May 14, 2026 08:03AM
May 14, 2026 08:00AM
Mar 18, 2026 08:00AM Cingulate Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
Feb 17, 2026 08:02AM
Feb 17, 2026 08:00AM
Nov 18, 2025 04:27PM
Nov 13, 2025 08:00AM
Nov 10, 2025 08:01AM
Nov 10, 2025 08:00AM
Oct 28, 2025 08:01AM Cingulate reports positive phase 3 trial results for ADHD drug CTx-1301
Oct 28, 2025 08:00AM
Oct 14, 2025 08:04AM
Oct 14, 2025 08:00AM
Aug 21, 2025 04:35PM
Aug 19, 2025 08:45AM
Jul 29, 2025 08:01AM
Jul 29, 2025 08:00AM Cingulate Receives $4.3M Waiver from FDA Ahead of Imminent Filing for Marketing Approval of Lead ADHD Asset CTx-1301

15,434 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All